Gland Pharma Limited
GLAND · NIFTYPHARMACounterparties, netted
2 parties disclosed across these transactions. 2 appeared on one side only.
| Counterparty | Disclosures | Buy | Sell | Net · ₹ Cr |
|---|---|---|---|---|
| NORTH ROCK SG VCC | 1 | 0 | 1 | −42 |
| BOFA SECURITIES EUROPE SA | 1 | 1 | 0 | +42 |
Net is purchases less sales across the disclosures collected, using the values the exchange published. It is arithmetic on what was disclosed, not a statement about why any party transacted.
Where this sits in the session
Measured against the 153 priced constituents the platform tracks, and against the 22 of them in Healthcare.
Most traded in Healthcare this session
| Company | Close | Change | Traded value |
|---|---|---|---|
| Divi's Laboratories LimitedDIVISLAB | 9,144.50 | +1.27% | ₹712 Cr |
| Apollo Hospitals Enterprise LimitedAPOLLOHOSP | 7,890.00 | +0.01% | ₹432 Cr |
| Max Healthcare Institute LimitedMAXHEALTH | 846.00 | −1.40% | ₹341 Cr |
| Laurus Labs LimitedLAURUSLABS | 2,060.10 | +2.06% | ₹331 Cr |
| Sun Pharmaceutical Industries LimitedSUNPHARMA | 1,758.80 | −0.29% | ₹268 Cr |
| Mankind Pharma LimitedMANKIND | 2,275.50 | −3.07% | ₹202 Cr |
| Zydus Lifesciences LimitedZYDUSLIFE | 1,123.00 | −1.51% | ₹180 Cr |
| Dr. Reddy's Laboratories LimitedDRREDDY | 1,233.00 | +1.17% | ₹155 Cr |
Traded value is closing price multiplied by reported volume. Shares are measured against the 153 deduplicated constituents of the nine tracked indices, not against the whole exchange. The sector average is unweighted, so a small member moves it as much as a large one; the member count sits beside it. Every sector ↗
Disclosed transactions
2 disclosed transactions across 1 session: 1 purchase, 1 sale
| Counterparty | Side | Quantity | Price | Value |
|---|---|---|---|---|
| 17 September 2026 | ₹0 Cr | |||
| BOFA SECURITIES EUROPE SAblock | BUY | 1,50,000 | ₹2,826.6 | ₹42 Cr |
| NORTH ROCK SG VCCblock | SELL | 1,50,000 | ₹2,826.6 | ₹42 Cr |
Substantial acquisitions
1 SEBI SAST filing
| Disclosed | Acquirer | Action | Route | Change | Holding after |
|---|---|---|---|---|---|
| 2026-09-22 | Fosun Pharma Industrial Pte. Ltd.promoter | Sale | Open Market | −6% | 45.76% |
Prices sourced from Yahoo Finance ↗. Transactions and SAST filings sourced from the National Stock Exchange ↗. No content on this page constitutes a recommendation, and no entry is inferred. Every line records a disclosure made by a publishing authority.